Certara (CERT) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $1.25B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Jon Resnick |
| IPO Date | 2020-12-11 | CAGR | 14.36% |
| Employees | 1,546 | Website | www.certara.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 5.82% | Total Yield | 5.82% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $1.12B | P/E | 20.02 | Forward P/E | 20.5 | PEG | — |
| P/S | 3.26 | P/B | 1.32 | P/CF | 15.62 | P/FCF | 20.94 |
| Sales | $395.63M | Sales 1Y | -2.5% | Sales 3Y | 12.37% | Sales 5Y | 51.13% |
| EPS | $0.4 | EPS 1Y | -961.63% | EPS 3Y | -460.57% | EPS 5Y | 7.97% |
| Sales QoQ | -24.76% | EPS QoQ | 529.5% | Sales QoQ Avg | -5.62% | EPS QoQ Avg | -22.99% |
| Gross Margin | 62.42% | Operating Margin | 1.92% | Profit Margin | -5.63% | ROCE | 0.59% |
| ROA | -2% | ROE | -2% | Altman Z Score | 1.88 | Piotroski Score | 7 |
| Current Ratio | 2.55 | Quick Ratio | 2.55 | Cash Ratio | 1.5 | Op. CF Ratio | 0.08 |
| Debt/Equity | 0.3 | Debt/Assets | 0.21 | Lt Debt/Equity | 0.3 | Lt Debt/Cap. | 0.23 |
| Intrst Cov. | 0.26 | Inventory Turnover | — | Asset Turnover | 0.28 | Receivables Turnover | 3.93 |
| Enterprise Value | $1.12B | P/E Ratio | 20.02 |
| Forward P/E | 20.5 | PEG Ratio | — |
| P/S Ratio | 3.26 | P/B Ratio | 1.32 |
| P/CF Ratio | 15.62 | P/FCF Ratio | 20.94 |
| EPS | $0.4 | EPS Growth 1Y | -961.63% |
| EPS Growth 3Y | -460.57% | EPS Growth 5Y | 7.97% |
| Revenue Growth 1Y | -2.5% | Gross Margin | 0.62% |
| Operating Margin | 0.02% | Profit Margin | -0.06% |
| ROE | -0.02% | ROA | -0.02% |
| ROCE | 0.01% | Current Ratio | 2.55 |
| Quick Ratio | 2.55 | Cash Ratio | 1.5 |
| Debt/Equity | 0.3 | Interest Coverage | 0.26 |
| Altman Z Score | 1.88 | Piotroski Score | 7 |
Certara (CERT) valuation & financials
Certara (CERT) has a market capitalization of $1.25B and trades at a price-to-earnings ratio of 20.0. It operates in the Healthcare sector (Medical - Healthcare Information Services).
Certara's revenue grew -2.5% over the last year.
Certara's next earnings report is scheduled for November 5, 2026 before market open; analysts estimate EPS of $0.09. Check the earnings calendar to see all companies reporting this week.
Certara (CERT) — frequently asked questions
When does Certara (CERT) report earnings next?
Certara is expected to report earnings on November 5, 2026 before market open. Analysts estimate EPS of $0.09.
What is Certara's market cap?
Certara (CERT) has a market capitalization of $1.25B.
What is CERT's P/E ratio?
Certara trades at a price-to-earnings ratio of 20.0, with trailing twelve-month EPS of $0.40.
How fast is Certara growing?
Certara's revenue grew -2.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)